Voyager Therapeutics (VYGR) Net Margin: 2015-2025
Historic Net Margin for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to -208.15%.
- Voyager Therapeutics' Net Margin fell 17143.00% to -208.15% in Q3 2025 from the same period last year, while for Sep 2025 it was -404.05%, marking a year-over-year decrease of 41985.00%. This contributed to the annual value of -81.25% for FY2024, which is 13418.00% down from last year.
- According to the latest figures from Q3 2025, Voyager Therapeutics' Net Margin is -208.15%, which was up 67.58% from -641.96% recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Net Margin registered a high of 1,524.26% during Q4 2022, and its lowest value of -3,239.97% during Q1 2022.
- Over the past 3 years, Voyager Therapeutics' median Net Margin value was -208.15% (recorded in 2025), while the average stood at -261.39%.
- Per our database at Business Quant, Voyager Therapeutics' Net Margin tumbled by 284,665bps in 2022 and then soared by 332,240bps in 2023.
- Quarterly analysis of 5 years shows Voyager Therapeutics' Net Margin stood at 20.34% in 2021, then spiked by 150,392bps to 1,524.26% in 2022, then crashed by 146,164bps to 62.62% in 2023, then plummeted by 61,195bps to -549.33% in 2024, then crashed by 17,143bps to -208.15% in 2025.
- Its last three reported values are -208.15% in Q3 2025, -641.96% for Q2 2025, and -477.25% during Q1 2025.